We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Mutations Sample Clauses

Mutations a) If Customer finds, induces, observes, or discovers an Essentially Derived Variety (hereinafter “E.D.V.”) such as any mutation or sport in any Flowering Only Product or Finished Plant, then Customer shall report the E.D.V. immediately to the Ball/Agent by registered letter. The letter shall include, at a minimum, the name for the Flowering Only Product or Finished Plant from which the E.D.V. has been induced, observed or discovered, and a brief description of the E.D.V. b) At the written request of the Ball/Agent, Customer shall immediately provide the Ball/Agent with sufficient material of the E.D.V. c) Ball or the third party owner of the Flowering Only Product (hereinafter "Third Party") if the Flowering Only Product is the subject of a third party license agreement, shall own all right, title and interest in the E.D.V. Customer hereby assigns all right, title, and interest in the E.D.V. to Ball or Third Party, if applicable. Customer agrees to cooperate with Ball or Third Party by executing any documents Ball or Third
Mutations. If and to the extent Mutations of the SARS-CoV-2 virus arise [***]
Mutations. The conserved residues in the NxxxNPxxY motif also seem to be very sensitive to mutation considering the behavior of the point mutants and our previous random mutagenesis results that did not identify any gain-of-function mutant by mutations in this region (Beukers et al., 2004a). Typically, homology models are based on the alignment of entire helical regions between rhodopsin and receptors with unknown structure. Loop areas are normally ignored or modeled based on databases of loop conformations. These models have been used to design experiments as well as to explain experimental data. We used the structure of bovine rhodopsin as a template to build a homology model of the human adenosine A2B receptor to guide the selection of amino acids for site-directed mutagenesis. The recent disclosure of the 3-D structure of the human β2 adrenergic receptor enabled us to make a homology model based on this template too. A structural overlay was made to investigate the differences between the two models with respect to the regions of interest in this study. The following differences were identified, i) the angle between helix 7 and 8, ii) the number of residues to link helix 7 and 8, iii) the location and side chain orientation of residues in the NxxxNPxxY motif, and iv) the nature of the salt bridge between helix 1 and helix 7. These findings suggest that care should be taken to interpret experimental data based on a single model. Cherezov already pointed to the shortcoming of homology models generated from a single structural template, as the structural divergence between two receptors would be quite difficult to predict accurately using only one receptor as a template (Cherezov et al., 2007). His conclusion was drawn from a similarity comparison between the β2 adrenergic receptor crystal structure and homology models of the β2 adrenergic receptor based on the structure of bovine rhodopsin and which were substantiated with biochemical data (Bissantz et al., 2003; Furse and Lybrand, 2003; Gouldson et al., 2004). Since the latter models used bovine rhodopsin as a template, they are more similar to the rhodopsin rather than the real β2 adrenergic receptor structure. Although all class A receptors share a similar backbone consisting of 7 transmembrane domains linked by extracellular and intracellular loops, each receptor has its own characteristics. Slight differences in the structure may result in significant differences in intramolecular interactions. For example, in...
Mutations. 1. The seller is entitled to make technically necessary changes to the sold goods without prior knowledge or knowledge of the purchaser. 2. Deviations of 10% of the ordered amount and in case of products that have been manufactured especially for the purchaser, deviations of 20%, are allowed. The seller will accordingly invoice the delivered amount to the purchaser. 3. Every delivery of a part of an ordered amount is considered as a separate transaction. The fulfillment or non-fulfillment of the delivery of a part of an ordered amount has no influence on the other parts of the order.
MutationsLicensee shall promptly notify NNII of any mutation that appears in any Licensed Cultivar nursery stock in Licensee’s possession or under Licensee’s control. Licensee acknowledges that the ownership of, and title to, any such mutation is retained by WSU. NNII and its representatives shall have unlimited access to Licensee’s premises during normal business hours, upon reasonable notice, to inspect all trees, budwood, and scion wood of the Licensed Cultivar and to remove all mutated plant material.
Mutations a) If Licensee finds, induces, observes, or discovers an Essentially Derived Variety (hereinafter “E.D.V.”) such as any mutation or sport in any Licensed Product or Finished Plant, then Licensee shall report the E.D.V. immediately to the Licensor/Agent by registered letter. The letter shall include, at a minimum, the name for the Licensed Product or Finished Plant from which the E.D.V. has been induced, observed or discovered, and a brief description of the E.D.V. b) At the written request of the Licensor/Agent the Licensee shall immediately provide the Licensor/Agent with sufficient material of the E.D.V. c) Licensor or the third party owner of the Licensed Product (hereinafter "Third Party") if the Licensed Product is the subject of a third party license agreement, shall own all right, title and interest in the E.D.V. Licensee hereby assigns all right, title, and interest in the E.D.V. to Licensor or Third Party, if applicable. Licensee agrees to cooperate with Licensor or Third Party by executing any documents Licensor

Related to Mutations

  • Contracts (Rights of Third Parties) Xxx 0000 No term of this Agreement is enforceable under the Contracts (Rights of Third Parties) Xxx 0000 by a person who is not a party to this Agreement.

  • Infectious Diseases The Employer and the Union desire to arrest the spread of infectious diseases in the nursing home. To achieve this objective, the Joint Health and Safety Committee may review and offer input into infection control programs and protocols including surveillance, outbreak control, isolation, precautions, worker education and training, and personal protective equipment. The Employer will provide training and ongoing education in communicable disease recognition, use of personal protective equipment, decontamination of equipment, and disposal of hazardous waste.

  • Immunizations (except for those preventive immunizations for routine use in children, adolescents, and adults that have in effect a recommendation from the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention);

  • Vaccinations Contractor understands, acknowledges, and agrees that, pursuant to Article II of the General Appropriations Act, none of the General Revenue Funds appropriated to the Department of State Health Services (DSHS) may be used for the purpose of promoting or advertising COVID-19 vaccinations in the 2024-25 biennium. It is also the intent of the legislature that to the extent allowed by federal law, any federal funds allocated to DSHS shall be expended for activities other than promoting or advertising COVID-19 vaccinations. Contractor represents and warrants that it is not ineligible, nor will it be ineligible during the term of this Contract, to receive appropriated funding pursuant to Article II.

  • Adverse Events Subsequent to the date hereof, there shall not have occurred any of the following: (i) a suspension or material limitation in trading in securities generally on the New York Stock Exchange, the NASDAQ National Market or the NASDAQ Global Market, (ii) a general moratorium on commercial banking activities in the People’s Republic of China or New York, (iii) the outbreak or escalation of hostilities involving the United States or the People’s Republic of China or the declaration by the United States or the People’s Republic of China of a national emergency or war if the effect of any such event specified in this clause (iii) in your reasonable judgment makes it impracticable or inadvisable to proceed with the public offering or the delivery of the Shares on the terms and in the manner contemplated in the Prospectus, or (iv) such a material adverse change in general economic, political, financial or international conditions affecting financial markets in the United States or the People’s Republic of China having a material adverse impact on trading prices of securities in general, as, in your reasonable judgment, makes it impracticable or inadvisable to proceed with the public offering of the Shares or the delivery of the Shares on the terms and in the manner contemplated in the Prospectus.

  • Intercept and Referral Announcements 6.1 When a Customer changes its service provider from Verizon to PW, or from PW to Verizon, and does not retain its original telephone number, the Party formerly providing service to such Customer shall provide a referral announcement (“Referral Announcement”) on the abandoned telephone number which provides the Customer’s new number or other appropriate information, to the extent known to the Party formerly providing service. Notwithstanding the foregoing, a Party shall not be obligated under this Section to provide a Referral Announcement if the Customer owes the Party unpaid overdue amounts or the Customer requests that no Referral Announcement be provided. 6.2 Referral Announcements shall be provided, in the case of business Customers, for a period of not less than one hundred and twenty (120) days after the date the Customer changes its telephone number, and, in the case of residential Customers, not less than thirty (30) days after the date the Customer changes its telephone number; provided that if a longer time period is required by Applicable Law, such longer time period shall apply. Except as otherwise provided by Applicable Law, the period for a referral may be shortened by the Party formerly providing service if a number shortage condition requires reassignment of the telephone number. 6.3 This referral announcement will be provided by each Party at no charge to the other Party; provided that the Party formerly providing service may bill the Customer its standard Tariff charge, if any, for the referral announcement.

  • Alterations and Attachments Student and Parent may not make any alterations in or add attachments, hardware, or software to the mobile device computer absent express permission from M-DCPS, which permission is at the sole option of M-DCPS.

  • Medications Psychotropic medications and medications associated with treating a diagnosed mental health condition.

  • Benefits of Agreement; No Third-Party Rights The provisions of this Agreement are intended solely to benefit the Member and, to the fullest extent permitted by applicable law, shall not be construed as conferring any benefit upon any creditor of the Company (and no such creditor shall be a third-party beneficiary of this Agreement), and the Member shall have no duty or obligation to any creditor of the Company to make any contributions or payments to the Company.

  • DEFINTIONS “Covered subcontract,” as used in this clause, means any subcontract, except a subcontract for the acquisition of commercial items or commercially available off-the-shelf items, that is in excess of $1 million and uses Fiscal Year 2010 funds. (b) The Contractor -